TY - JOUR
T1 - Structure of the hybrid-2 type intramolecular human telomeric G-quadruplex in K+ solution
T2 - Insights into structure polymorphism of the human telomeric sequence
AU - Dai, Jixun
AU - Carver, Megan
AU - Punchihewa, Chandanamali
AU - Jones, Roger A.
AU - Yang, Danzhou
N1 - Funding Information:
This result was presented at the ‘‘First International Meeting on Quadruplex DNA’’ held in Louisville, KY, USA on April 21–24, 2007 (http://pubs.acs.org/cen/coverstory/ 85/8522aboutcover.html). We thank Dr Laurence Hurley for insightful comments and suggestions. This research was supported by the National Institutes of Health (1K01CA83886 and 1S10 RR16659). Funding to pay the Open Access publication charges for this article was waived by Oxford University Press.
PY - 2007/8
Y1 - 2007/8
N2 - Formation of the G-quadruplex in the human telomeric sequence can inhibit the activity of telomerase, thus the intramolecular telomeric G-quadruplexes have been considered as an attractive anticancer target. Information of intramolecular telomeric G-quadruplex structures formed under physiological conditions is important for structure-based drug design. Here, we report the first structure of the major intramolecular G-quadruplex formed in a native, non-modified human telomeric sequence in K+ solution. This is a hybrid-type mixed parallel/ antiparallel-G-stranded G-quadruplex, one end of which is covered by a novel T:A:T triple capping structure. This structure (Hybrid-2) and the previously reported Hybrid-1 structure differ in their loop arrangements, strand orientations and capping structures. The distinct capping structures appear to be crucial for the favored formation of the specific hybrid-type intramolecular telomeric G-quadruplexes, and may provide specific binding sites for drug targeting. Our study also shows that while the hybrid-type G-quadruplexes appear to be the major conformations in K+ solution, human telomeric sequences are always in equilibrium between Hybrid-1 and Hybrid-2 structures, which is largely determined by the 3′-flanking sequence. Furthermore, both hybrid-type G-quadruplexes suggest a straightforward means for multimer formation with effective packing in the human telomeric sequence and provide important implications for drug targeting of G-quadruplexes in human telomeres.
AB - Formation of the G-quadruplex in the human telomeric sequence can inhibit the activity of telomerase, thus the intramolecular telomeric G-quadruplexes have been considered as an attractive anticancer target. Information of intramolecular telomeric G-quadruplex structures formed under physiological conditions is important for structure-based drug design. Here, we report the first structure of the major intramolecular G-quadruplex formed in a native, non-modified human telomeric sequence in K+ solution. This is a hybrid-type mixed parallel/ antiparallel-G-stranded G-quadruplex, one end of which is covered by a novel T:A:T triple capping structure. This structure (Hybrid-2) and the previously reported Hybrid-1 structure differ in their loop arrangements, strand orientations and capping structures. The distinct capping structures appear to be crucial for the favored formation of the specific hybrid-type intramolecular telomeric G-quadruplexes, and may provide specific binding sites for drug targeting. Our study also shows that while the hybrid-type G-quadruplexes appear to be the major conformations in K+ solution, human telomeric sequences are always in equilibrium between Hybrid-1 and Hybrid-2 structures, which is largely determined by the 3′-flanking sequence. Furthermore, both hybrid-type G-quadruplexes suggest a straightforward means for multimer formation with effective packing in the human telomeric sequence and provide important implications for drug targeting of G-quadruplexes in human telomeres.
UR - http://www.scopus.com/inward/record.url?scp=34548550548&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34548550548&partnerID=8YFLogxK
U2 - 10.1093/nar/gkm522
DO - 10.1093/nar/gkm522
M3 - Article
C2 - 17626043
AN - SCOPUS:34548550548
SN - 0305-1048
VL - 35
SP - 4927
EP - 4940
JO - Nucleic acids research
JF - Nucleic acids research
IS - 15
ER -